Dental Tribune India

Mucor due to hyperglycemia from new strain?

By Rajeev Chitguppi, Dental Tribune South Asia
May 23, 2021

As the medical fraternity gets busy identifying the risk factors and causative factors behind mucormycosis, a clinical observation of six months suggests it could be due to severe hyperglycemia caused by the new variant of SARS-CoV-2.

A tweet from the Head of Dept, Rheumatology, AIIMS, New Delhi questioned the current notion that steroids could be the cause of sudden surge seen in mucormycosis cases.

Her tweet, which suspected an interaction between COVID-19 and immunity being responsible for mucormycosis, received a prompt response from Dr. Om Lakhani, consulting endocrinologist, Zydus hospitals who suggested 'poor glycemic control' as the key factor behind mucormycosis surge.

Dr. Lakhani suggests that our current notion that mucormycosis was mainly seen in hospitalized patients is wrong. He also questioned the current claims of oxygen supplementation being responsible for mucormycosis.

Dr. Lakhani suggests severe hyperglycemia caused by the new strain as the key factor behind mucormycosis.

Even though the earlier strain caused hyperglycemia, it was not that severe. The current strain is causing severe hyperglycemia.

However, it is not just hyperglycemia but its interaction with COVID-19 that is causing mucormycosis.

He suggests the use of Insulin and Oral Antidiabetic Drugs (OAD) for the management of hyperglycemia.

Leave a Reply

Your email address will not be published. Required fields are marked *

© 2021 - All rights reserved - Dental Tribune International